# Real‐world efficacy and safety of universal 8‐week glecaprevir/pibrentasvir in patients with chronic hepatitis C with early chronic kidney disease or pre‐end‐stage renal disease: Insights from a nationwide hepatisis <scp>C virus</scp> registry in Taiwan

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-efficacy-and-safety-of-universal-8-week-glecaprevir-pibrentasvir-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | S J Wang,Chung‐Feng Huang,Te Sheng Chang,C. Lo,Chao Hung Hung,Cheng Huang,Lee Chong,Pin Nan Cheng,Ming-Lun Yeh,Cheng‐Yuan Peng,Chi-Yin Cheng,Jee Fu Huang,Ming Jong Bair,Chih Lang Lin,Chi Chieh Yang,H.-T. Kuo,Tsai Yuan Hsieh,Tzong Hsi Lee,Pei Lun Lee,Wen Chih Wu,Chih Lin Lin,Wei Su,Sheng‐Shun Yang,Chia Chi Wang,Jui Ting Hu,Lein Ray Mo,Chun Chen,Yi‐Hsiang Huang,Chun-Chao Chang,Chia‐Sheng Huang,G. Chen,C. L. Kao,Chi‐Ming Tai,Chun‐Jen Liu,Mei‐Hsuan Lee,Pei‐Chien Tsai,Chia Yen Dai,Jia‐Horng Kao,Han Lin,Wan‐Long Chuang,Kuo Chih Tseng,Chi Yi Chen,Shu‐Chi Wang,Ming‐Lung Yu |
| Citations | 4 |
| DOI | 10.1002/kjm2.12929 |
| Fields | Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://doi.org/10.1002/kjm2.12929 |
| OpenAlex ID | https://openalex.org/W4406597796 |
| PMID | 39829106 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Chun-Chao Chang](https://scholariq.org/researchers/chun-chao-chang/)

## Paper primary topic

- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)

## Paper topics

- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.